The positive and negative syndrome scale (PANSS) for schizophrenia.
Kay SR, Fiszbein A, Opler LA.
Schizophr Bull. 1987;13(2):261-76. doi: 10.1093/schbul/13.2.261.
Sparse factors for the positive and negative syndrome scale: which symptoms and stage of illness?
Anderson A, Wilcox M, Savitz A, Chung H, Li Q, Salvadore G, Wang D, Nuamah I, Riese SP, Bilder RM.
Psychiatry Res. 2015 Feb 28;225(3):283-90. doi: 10.1016/j.psychres.2014.12.025. Epub 2015 Jan 6.
The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis.
Emsley R, Rabinowitz J, Torreman M; RIS-INT-35 Early Psychosis Global Working Group.
Schizophr Res. 2003 May 1;61(1):47-57. doi: 10.1016/s0920-9964(02)00302-x.
Burnout syndrome in intensive care professionals: relationships with health status and wellbeing.
Arrogante O, Aparicio-Zaldivar EG.
Enferm Intensiva (Engl Ed). 2020 Apr-Jun;31(2):60-70. doi: 10.1016/j.enfi.2019.03.004. Epub 2019 Jun 26.
Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison.
Kay SR.
Psychiatr Q. 1990 Fall;61(3):163-78. doi: 10.1007/BF01064966.
The Positive and Negative Syndrome Scale--Spanish adaptation.
Kay SR, Fiszbein A, Vital-Herne M, Fuentes LS.
J Nerv Ment Dis. 1990 Aug;178(8):510-7.
[The PANSS (Positive And Negative Symptom) Scale].
Guelfi JD.
Encephale. 1997 Apr;23 Spec No 2:35-8.
Can the Positive and Negative Syndrome scale (PANSS) differentiate treatment-resistant from non-treatment-resistant schizophrenia? A factor analytic investigation based on data from the Pattern cohort study.
Freitas R, Dos Santos B, Altamura C, Bernasconi C, Corral R, Evans J, Malla A, Krebs MO, Nordstroem AL, Zink M, Haro JM, Elkis H.
Psychiatry Res. 2019 Jun;276:210-217. doi: 10.1016/j.psychres.2019.05.002. Epub 2019 May 8.
Reliability and validity of the positive and negative syndrome scale for schizophrenics.
Kay SR, Opler LA, Lindenmayer JP.
Psychiatry Res. 1988 Jan;23(1):99-110. doi: 10.1016/0165-1781(88)90038-8.
Initial severity of the Positive and Negative Syndrome Scale (PANSS)-30, its main subscales plus the PANSS-6, and the relationship to subsequent improvement and trial dropout: a pooled participant-level analysis of 18 placebo-controlled risperidone and paliperidone trials.
Hieronymus F, Correll CU, Østergaard SD.
Transl Psychiatry. 2023 Jun 7;13(1):191. doi: 10.1038/s41398-023-02491-6.
